TIANYIN PHARMACEUTICAL CO., INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2014 12 months to Jun 30, 2014	FY2013 12 months to Jun 30, 2013	FY2012 12 months to Jun 30, 2012
Sales
Cost of sales
Gross profit
Operating expenses
Selling expenses
General and administrative expenses
Research and development
Total operating expenses
Income from operations
Other income (expenses):
Interest income
Interest expense
Other income
Other expense
Total other income (expenses)
Income (loss) before provision for income tax
Provision for income tax
Net income (loss)
Less: Net income (loss) attributable to noncontrolling interest
Net income attributable to Tianyin Pharmaceutical Co., Inc.
Basic earnings per share
Basic and diluted earnings per share
Weighted average number of common shares outstanding:
Basic
Basic and diluted

Comments